BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 24, 2011
View Archived Issues
Researchers describe discovery and development of hepatitis C treatment GS-5885
Read More
Scientists present two new agents against herpes simplex virus
Read More
FDA approves use of Edurant in treatment-naive adults with HIV-1
Read More
PMX-30063 shows activity against oral mucositis in animal study
Read More
PRM-151 is safe and active in healthy volunteers and in subjects with idiopathic pulmonary fibrosis
Read More
PF-4357415 is superior to fluticasone propionate in rat model of lung inflammation
Read More
Phase II data disclosed on tanezumab in chronic prostatitis/chronic pelvic pain syndrome
Read More
First patients enrolled in phase I trial of Glycotope's FSH-GEX
Read More
Thermo Fisher Scientific signs definitive agreement to acquire Phadia
Read More
Novartis confirms new divisional structure following merger with Alcon
Read More
Themis Bioscience raises funds to advance vaccine candidates
Read More
New delta opioid receptor antagonists reported by Janssen group
Read More
KIST presents novel protein kinase inhibitors for cancer
Read More
Merck & Co. describes new phosphodiesterase 10A inhibitors
Read More
New closthioamides presented
Read More
Scientists prepare new adenosine A2A receptor antagonists
Read More
Sosei launches NorLevo emergency contraceptive pill in Japan
Read More
FDA approves Incivek for genotype 1 chronic hepatitis C
Read More
Nexavar plus standard chemotherapy improves progression-free survival of patients with breast cancer
Read More
Genentech reports phase II data on MetMAb/Tarceva in NSCLC
Read More
Gactiv approved in Japan for type 2 diabetes in combination with alpha-glucosidase inhibitors
Read More
VivaGel is efficacious in phase II trial in bacterial vaginosis
Read More
Abbott to submit ALK FISH test for approval in Japan and U.S.
Read More
Daiichi Sankyo and AstraZeneca enter copromotion agreement for denosumab in Japan
Read More
EMA's CHMP recommends label extension for tocilizumab
Read More